Beperminogene perplasmid

N/A

Report date: 2024/09/19 15:03:39

Base Information

Drug NameBeperminogene perplasmid
Drug Alias NameHepatocyte growth factor gene therapy培米诺近培米诺集beperminogenum perplasmidum珀-贝米诺近 +[11] 
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionHepatocyte growth factor stimulantsAngiogenesis inducers
TargetsHepatocyte growth factor
Therapy Area/IndicationsUlcerIschemiaFoot Ulcer +[8] 
Global Approved IndicationsIschemiaPeripheral Arterial Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/03/01
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAnges MgOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesAnges IncMitsubishi Tanabe Pharma
Inactive CompaniesAnges Usa Inc
Active IndicationsIschemiaPeripheral Arterial Disease
Inactive IndicationsUlcerFoot UlcerPeripheral Vascular Diseases +[6] 

Other Information

ATC CodeV09G
Related LinksN/A